Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

Past studies show one of the most potentially harmful areas to accumulate fat is visceral fat within the abdominal area.

A new study suggests you may want to pay better attention to your HDL cholesterol — but not for the reason you might think.

Novo Nordisk GLP-1 fails to slow Alzheimer's in phase 3 trials involving 3,808 adults with mild cognitive impairment or dementia.

Vascular dementia is the second-most common form of dementia after Alzheimer's. About 2.7 million people in the U.S. are thought to have mixed dementia or vascular dementia, which is caused by strokes ...

Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...